page-header

Category: News

VET-CXL effective and safe in the treatment of septic corneal ulcers in horses

The results of the randomized controlled clinical trial on efficacy of Vetuvir in the treatment of septic corneal ulcers in…

VET-CXL®, supporting evidences on corneal ulcer healing process

One of the main advantages of VET-CXL® is the healing process, which allows the cornea to restore its transparency to…

EQUIRVIS™, a unique ophthalmic solution developed exclusively for VET-CXL™

The continuous improvement in product development by Vision Engineering Italy has led to EQUIRVIS™, a high concentration riboflavin ophthalmic solution…

VETUVIR, the revolution in veterinary ophthalmology

Vetuvir is the first UV-A medical device developed for exclusive use in veterinary medicine for the treatment of corneal infections…

VISION ENGINEERING ITALY, the success of a user driven medtech product engineering Company. How VET-CXL® was born.

Vision Engineering Italy is a medtech company focused to research & development of breakthrough technological solutions to unmet needs in…

VET-CXL®: how does it work?

The VET-CXL® protocol consists of irradiating the cornea with high UV-A power density, 30 mW/cm2, after soaking the tissue with…